Revelation Biosciences Inc (REVB) — Financial Flexibility Index
Revelation Biosciences Inc (REVB) has a Financial Flexibility Index of -1.53x as of March 2026. Free cash flow of $-3.14 Million (operating CF $-3.21 Million minus capex $71.88K) represents -2% of total liabilities ($2.06 Million). Also explore REVB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Revelation Biosciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Revelation Biosciences Inc across 10 annual periods. Check REVB strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Revelation Biosciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Revelation Biosciences Inc. For the full company profile including market capitalisation, see market value of Revelation Biosciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.04x | $-8.27 Million | $-8.27 Million | $2.72 Million | ▲ +68.2% |
| 2024 | -9.56x | $-18.30 Million | $-18.32 Million | $1.91 Million | ▼ -630.4% |
| 2023 | -1.31x | $-7.29 Million | $-7.29 Million | $5.56 Million | ▲ +48.1% |
| 2022 | -2.52x | $-11.22 Million | $-11.22 Million | $4.45 Million | ▲ +50.7% |
| 2021 | -5.12x | $-10.96 Million | $-11.09 Million | $2.14 Million | ▼ -2775.9% |
| 2020 | -0.18x | $-215.07K | $-215.07K | $1.21 Million | ▼ -100.0% |
| 2019 | 1581.66x | $41.61 Million | $41.09 Million | $26.31K | ▲ +10359799.7% |
| 2018 | 0.02x | $33.44 Million | $32.58 Million | $2.19 Billion | ▲ +16.4% |
| 2017 | 0.01x | $25.05 Million | $24.25 Million | $1.91 Billion | ▲ +85.7% |
| 2016 | 0.01x | $12.18 Million | $11.60 Million | $1.73 Billion | — |